Fate Therapeutics, Inc. Competitors

FATE 
$4.9
*  
0.01
0.2%
Get FATE Alerts
*Delayed - data as of Jan. 27, 2015  -  Find a broker to begin trading FATE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    FATE Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Fate Therapeutics, Inc.
CompanyName
Symbol: Market ▼
LastSale NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Acorda Therapeutics, Inc.
ACOR: NASDAQ-GS
$ 43.70 -0.80 ▼ 412,329 $ 44.30
$ 43.33
$ 45.45
$ 28.26
78.04 1,833,127,600
Amgen Inc.
AMGN: NASDAQ-GS
$ 158.89 -0.84 ▼ 2,876,264 $ 160.74
$ 158.278
$ 173.14
$ 108.20
25.02 120,862,856,300
ARIAD Pharmaceuticals, Inc.
ARIA: NASDAQ-GS
$ 6.46 0.09 ▲ 4,179,335 $ 6.59
$ 6.27
$ 9.74
$ 4.90
NE 1,209,389,520
Atara Biotherapeutics, Inc.
ATRA: NASDAQ-GS
$ 24.64 0.81 ▲ 57,153 $ 25.20
$ 23.96
$ 35.45
$ 9.66
NE 498,048,320
BioCryst Pharmaceuticals, Inc.
BCRX: NASDAQ-GS
$ 11.06 -0.27 ▼ 527,175 $ 11.29
$ 10.96
$ 14.62
$ 7.29
NE 794,815,840
Biogen Idec Inc.
BIIB: NASDAQ-GS
$ 357.89 -4.55 ▼ 1,446,335 $ 364.76
$ 357.13
$ 366.17
$ 272.02
33.86 84,517,512,950
bluebird bio, Inc.
BLUE: NASDAQ-GS
$ 97.36 -0.42 ▼ 611,002 $ 100.11
$ 94.01
$ 106.23
$ 17.40
NE 2,806,207,280
Biota Pharmaceuticals, Inc.
BOTA: NASDAQ-GS
$ 2.55 -0.09 ▼ 34,836 $ 2.63
$ 2.51
$ 7.07
$ 2.10
NE 89,507,550
China Biologic Products, Inc.
CBPO: NASDAQ-GS
$ 68.60 -0.63 ▼ 82,179 $ 69.432
$ 68.14
$ 71.27
$ 27.34
26.69 1,691,470,200
DBV Technologies S.A.
DBVT: NASDAQ-GS
$ 25.94 0.50 ▲ 28,815 $ 25.94
$ 25.45
$ 28.50
$ 22.20
NE 956,926,600
Synageva BioPharma Corp.
GEVA: NASDAQ-GS
$ 119.77 -1.15 ▼ 323,918 $ 122.75
$ 118.675
$ 122.88
$ 60.19
NE 4,412,566,340
Gilead Sciences, Inc.
GILD: NASDAQ-GS
$ 105.03 -2.08 ▼ 10,341,071 $ 107.02
$ 104.86
$ 116.83
$ 63.50
18.52 158,454,979,920
Halozyme Therapeutics, Inc.
HALO: NASDAQ-GS
$ 14.48 0.04 ▲ 1,198,959 $ 14.80
$ 14.10
$ 16.84
$ 6.88
NE 1,815,603,760
Kite Pharma, Inc.
KITE: NASDAQ-GS
$ 74.78 3.41 ▲ 1,674,661 $ 76.385
$ 69.55
$ 89.21
$ 21
NE 2,867,738,220
Momenta Pharmaceuticals, Inc.
MNTA: NASDAQ-GS
$ 10.82 -0.04 ▼ 445,541 $ 11
$ 10.68
$ 19.16
$ 9.38
NE 574,011,820
Neurocrine Biosciences, Inc.
NBIX: NASDAQ-GS
$ 33.54 -0.01 ▼ 820,859 $ 34.31
$ 32.80
$ 33.59
$ 12.17
NE 2,549,207,700
NPS Pharmaceuticals, Inc.
NPSP: NASDAQ-GS
$ 45.92 -0.01 ▼ 2,828,577 $ 45.965
$ 45.90
$ 46.01
$ 22.11
4592 4,906,092,800
Novavax, Inc.
NVAX: NASDAQ-GS
$ 7.82 0.22 ▲ 5,128,205 $ 7.915
$ 7.50
$ 7.74
$ 3.34
NE 1,864,897,960
PDL BioPharma, Inc.
PDLI: NASDAQ-GS
$ 7.72 0.09 ▲ 2,567,075 $ 7.7699
$ 7.55
$ 10.26
$ 7.16
3.94 1,240,248,880
Qiagen N.V.
QGEN: NASDAQ-GS
$ 23.65 -0.11 ▼ 1,301,949 $ 23.79
$ 23.10
$ 25.32
$ 19.46
37.54 5,518,845,750
Repligen Corporation
RGEN: NASDAQ-GS
$ 25.47 0.26 ▲ 217,058 $ 25.79
$ 24.81
$ 26.75
$ 12.04
70.75 833,429,340
Seattle Genetics, Inc.
SGEN: NASDAQ-GS
$ 33.20 0.18 ▲ 987,600 $ 33.66
$ 32.565
$ 55.99
$ 30.05
NE 4,113,214,400
Sangamo BioSciences, Inc.
SGMO: NASDAQ-GS
$ 13.79 0.07 ▲ 560,786 $ 14.03
$ 13.36
$ 24.69
$ 9.39
NE 943,291,160
Bio-Techne Corp
TECH: NASDAQ-GS
$ 93.15 -0.30 ▼ 160,907 $ 94.30
$ 92.42
$ 97.15
$ 82.51
32.23 3,453,629,400
Vical Incorporated
VICL: NASDAQ-GS
$ 1.03 -0.05 ▼ 287,338 $ 1.07
$ 1.02
$ 1.66
$ .8936
NE 93,039,900